- conflicts or gaps
- [{"headquarters_discrepancy": {"value": "YC and LinkedIn list San Francisco; FDA orphan-drug sponsor and SBIR list San Carlos address (733 Industrial Road)", "source_urls": ["https://www.ycombinator.com/companies/altay-therapeutics", "https://www.linkedin.com/company/altay-therapeutics", "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1102825", "https://www.sbir.gov/portfolio/1692679"]}, "employee_count_discrepancy": {"value": "LinkedIn reports 4 employees; YC, SBIR, and GetLatka report 6", "source_urls": ["https://www.linkedin.com/company/altay-therapeutics", "https://www.ycombinator.com/companies/altay-therapeutics", "https://www.sbir.gov/portfolio/1692679", "https://getlatka.com/companies/altaytherapeutics.com"]}, "total_funding_discrepancy": {"value": "LinkedIn aggregate USD 3.36M vs Tracxn USD 6.71M; Tachyon Ventures seed amount undisclosed; Tracxn latest 2025 grant amount redacted", "source_urls": ["https://www.linkedin.com/company/altay-therapeutics", "https://tracxn.com/d/companies/altaytherapeutics/__meIv79WjJ0Cha6ARfNLtAeTpa4d4ClBCJaDsQvqlrUg"]}, "leadership_title_discrepancy": {"value": "Ali Ozes listed as Co-Founder and CEO in Sep 2022 Solve FSHD release; company website and LinkedIn list Jim Breitmeyer as CEO and Ali Ozes as Founder/CSO", "source_urls": ["https://www.globenewswire.com/news-release/2022/09/21/2520372/0/en/SOLVE-FSHD-invests-US-3-million-in-Altay-Therapeutics.html", "https://altaytherapeutics.com", "https://www.linkedin.com/company/altay-therapeutics"]}, "stale_yc_profile": {"value": "YC company page still describes liver fibrosis/cancer focus and projected clinic-ready compound by end-2021 and Phase I by mid-2022, which appear unmet vs current FSHD-focused preclinical status", "source_urls": ["https://www.ycombinator.com/companies/altay-therapeutics", "https://altaytherapeutics.com"]}, "clinical_timeline_gap": {"value": "No Phase I trials identified as started; website shows DX5057 Phase 1/2a planned around 2026 despite earlier YC-stated 2022 Phase I target", "source_urls": ["https://www.ycombinator.com/companies/altay-therapeutics", "https://altaytherapeutics.com", "https://www.fshdsociety.org/2026/01/11/arts-call-to-action/"]}, "revenue_claim_unverified": {"value": "GetLatka claims ~USD 900K revenue in 2024 for a preclinical biotech; not corroborated by primary company or regulatory sources", "source_urls": ["https://getlatka.com/companies/altaytherapeutics.com", "https://altaytherapeutics.com"]}, "data_freshness_gaps": {"value": "Third-party databases (YC, LinkedIn, Tracxn, GetLatka) show inconsistent counts, funding totals, and titles; company website is most current on pipeline stage and leadership as of fetch date", "source_urls": ["https://www.ycombinator.com/companies/altay-therapeutics", "https://www.linkedin.com/company/altay-therapeutics", "https://tracxn.com/d/companies/altaytherapeutics/__meIv79WjJ0Cha6ARfNLtAeTpa4d4ClBCJaDsQvqlrUg", "https://altaytherapeutics.com"]}}]
- source urls
- ["https://altaytherapeutics.com", "https://biobase.whitefordresearch.com/companies/altay-therapeutics", "https://getlatka.com/companies/altaytherapeutics.com", "https://st.ventureradar.com/organisation/Altay%20Therapeutics/0002cabb-1455-4c07-a6ff-b9e333fdece7", "https://tracxn.com/d/companies/altaytherapeutics/__meIv79WjJ0Cha6ARfNLtAeTpa4d4ClBCJaDsQvqlrUg", "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1102825", "https://www.crunchbase.com/organization/altay-therapeutics", "https://www.crunchbase.com/person/ali-ozes", "https://www.crunchbase.com/person/osman-nidai-ozes", "https://www.fshdsociety.org/2026/01/11/arts-call-to-action/", "https://www.fshfriends.org/blog/altay-therapeutics-receives-orphan-drug-designationfor-dx5057", "https://www.globenewswire.com/news-release/2022/09/21/2520372/0/en/SOLVE-FSHD-invests-US-3-million-in-Altay-Therapeutics.html", "https://www.highergov.com/grant/2233404/", "https://www.linkedin.com/company/altay-therapeutics", "https://www.sbir.gov/awards/200459", "https://www.sbir.gov/awards/200581", "https://www.sbir.gov/awards/200885", "https://www.sbir.gov/awards/202196", "https://www.sbir.gov/awards/213292", "https://www.sbir.gov/portfolio/1692679", "https://www.ycombinator.com/companies/altay-therapeutics"]